Sage Journals: Discover world-class research

Abstract

Purpose

Lower extremity spasticity can cause pain and limit function. This study examined the safety and efficacy of hyperselective neurectomy (HSN) of the gastrocnemius-soleus complex (GSC) in addressing spastic equinus deformities in pediatric patients.

Methods

Pediatric patients that underwent HSN of the GSC by a single surgeon were retrospectively reviewed. Preoperative and postoperative Modified Ashworth Score and passive ankle dorsiflexion (°) were compared using Wilcoxon signed-rank test and Student's paired two-tailed t-test, respectively.

Results

Ten lower extremities in seven patients with a mean age of 10 years were reviewed. Mean follow-up was 15 months. All extremities demonstrated improvement in spasticity. All exhibited improved passive ankle dorsiflexion range of motion with the knee in extension (mean change +17°, SD = 8°, p = 0.000). Five patients demonstrated improved passive dorsiflexion with the knee in flexion while two remained unchanged from preoperative assessment (mean change +13°, SD = 9°, p = 0.002). One complication, wound dehiscence, was noted and managed conservatively. No patients reported loss of strength or sensation. Four patients underwent subsequent staged surgery on the ipsilateral extremity for concomitant contractures.

Conclusion

HSN of the GSC is safe in pediatric patients and effectively reduces spastic equinus deformity and improves ankle passive dorsiflexion in short-term follow-up.

Keywords

neurectomy spasticity equinovarus cerebral palsy upper motor neuron injury

Introduction

Spasticity is a velocity-dependent resistance to stretch applied to a muscle group across a joint.¹ Spasticity is commonly observed in individuals with congenital or acquired upper motor neuron (UMN) injuries including cerebral palsy, traumatic brain injury, stroke, and spinal cord injury. The disruption of normal inhibitory UMN pathways interrupts inhibitory influences and causes heightened excitability of spinal reflexes.² This leads to reduced motor control and discoordination between agonistic and antagonistic muscle groups. If not addressed, spasticity can lead to progressive muscle and joint contractures, markedly affecting gait, posture, function, and self-care.

Specifically, individuals with spastic hemiplegia commonly exhibit equinus foot deformities and abnormal gait patterns.³ Spasticity within the gastrocnemius and soleus muscles, otherwise known as the gastrocnemius-soleus complex (GSC), drives equinus deformity while concomitant posterior tibialis (PT) muscle spasticity results in an equinovarus deformity.^4,5 Addressing spastic posturing of the foot and ankle optimizes initiation and termination of gait, improves balance, and mitigates the development of fixed equinus or equinovarus deformities. Furthermore, in children, these deformities can occur rapidly during growth due to the imbalance in agonist and antagonist muscles and underlying spasticity.⁶

Non-operative management of lower extremity (LE) spasticity typically involves a combination of physical therapy, orthoses, anti-spasmodic medications, and chemical denervation.^6,7 When positioning, function, or deformity worsen, surgery may provide lasting relief by targeting spasticity at the level of the muscle, tendon, or peripheral nerve.⁸ Surgical treatment may include muscle release/recession, tendon lengthening/tenotomy, and nerve-based procedures such as selective dorsal rhizotomy (SDR) and partial or selective motor nerve neurectomy.^9–11 Spasticity without muscle or joint contracture can be effectively treated by nerve-based procedures alone, while spasticity with muscle contracture may be best addressed with nerve-based procedures in conjunction with muscle-tendon lengthening procedures. Of note, muscle-tendon lengthening procedures have variable long-term efficacy in children, likely due to ongoing longitudinal skeletal growth with ongoing spasticity.¹²

Nerve-based procedures to address spasticity may involve several targets within the peripheral nerve. SDR involves sectioning portions of the dorsal nerve root, permanently reducing spasticity, yet can have unintended weakening of non-spastic muscles.⁶ Total, partial, and selective neurectomies target peripheral nerves downstream of this location (Table 1). Neurectomy consists of excising a segment of nerve to prevent unwanted axonal regeneration and motor reinnervation. Partial motor neurectomy and selective motor neurectomy were first described in the LE by Adolf Stoffel in 1913 to disrupt the neural reflex arc that facilitates spasticity.¹³ These procedures target either the main motor branch or the primary branch of the main motor nerve. In 1983, Brunelli et al. improved the technique for selective neurectomy in the upper extremity with more extensive nerve resection, though over half required a second surgery due to recurrence of spasticity.⁹ Subsequently, Sindou and Mertens furthered the technique by introducing fascicular dissections via a microscope.^11,14

Table 1.

Nomenclature of neurectomy based on location within the peripheral nerve.

Procedure	Target within the peripheral nerve
Neurectomy	Main trunk
Total motor neurectomy	Main motor branch
Partial motor neurectomy	Main motor branch
Selective total motor neurectomy	Primary branch of main motor nerve
Selective partial motor neurectomy	Primary branch of main motor nerve
Hyperselective motor neurectomy	Secondary (intramuscular) branch, or terminal rami, of motor nerve

Neurectomy – resection of a nerve segment, Total – complete nerve, Partial – portion of nerve.

Leclercq et al. further refined this technique as hyperselective neurectomy (HSN). Although initially reported in the LE, recent literature has pertained to surgery of the upper extremity.¹⁰ Compared with other nerve-based procedures, such as SDR, HSN offers the advantage of specifically targeting the motor rami as it interfaces with the target muscle at the motor endplate, thus minimizing collateral neuromotor dysfunction or injury (Table 1).

The safety and efficacy of HSN of the upper extremity and selective partial motor neurectomy of the LE in children and adults with hypertonia is well-described; however, HSN of the GSC has not been evaluated.^9–11,15 As HSN can offer permanent spasticity reduction critical for reducing deformity, especially in children for whom muscle and tendon based procedures can recur with skeletal growth, the purpose of this study was to determine the efficacy and safety of HSN in addressing primary spastic equinus deformity within a pediatric population.

Methods

Clinical patient cohort

A retrospective chart review was performed for pediatric patients (<18 years old) who underwent HSN of the GSC by a single surgeon (P.C.R.) at a tertiary referral institution from 2020 to 2023. Institutional ethics approval was obtained prior to the study.

Outcome measures

Patient charts were reviewed for demographic information, underlying diagnoses, and Gross Motor Functional Classification Score (GMFCS) for those with cerebral palsy. Outcome measures included pre- and postoperative Modified Ashworth Scale (MAS), motor strength (Medical Research Council scale), sensory disturbance, passive ankle dorsiflexion (°) with the knee in flexion and extension, and use of gait aids/ankle-foot orthoses.¹⁶ Passive dorsiflexion was assessed with a handheld goniometer with the patient in supine position. The presence of a gastrocnemius contracture was determined based on physical examination, specifically by comparing passive ankle dorsiflexion with the knee in flexion versus extension. Major complications were defined as those requiring return to the operating room and minor complications as those managed non-operatively.

Multidisciplinary approach

Patients were initially evaluated by a multidisciplinary team and non-operative spasticity management was guided by a physical medicine and rehabilitation (PMR) physician. Treatments included chemical denervation with botulinum toxin, phenol, and/or oral antispasmodics. For ambulatory patients considering surgical spasticity management, dynamic electromyography (EMG) and gait/motion analyses with a comprehensive assessment facilitated the development of an individualized surgical treatment plan for HSN. The assessment team included pediatric orthopedic, foot/ankle and peripheral nerve surgeons. HSN was followed by a period of physical therapy, including gait retraining. Follow-up evaluation determined if additional muscle, tendon, or joint procedures were necessary to address residual deformity.

Surgical technique

HSN was performed under tourniquet control through a longitudinal incision in the midline of the posterior aspect of the leg, extending from the popliteal crease to the middle third of the calf. The sural nerve and lesser saphenous vein were identified coursing between the medial and lateral heads of the gastrocnemius. Retrograde dissection of the sural nerve facilitated identification of the tibial nerve deep within the popliteal fossa. Antegrade dissection along the tibial nerve revealed the origin of the motor branches to the medial and lateral heads of the gastrocnemius muscles and the motor branches to the soleus muscle Figure 1. There are usually one to two motor branches to the medial gastrocnemius, lateral gastrocnemius, and soleus Figure 2.^17,18

Figure 1.

Tibial and sural nerves and motor nerve branches to the medial head of the gastrocnemius and soleus in a right lower extremity.

Figure 2.

Terminal rami of the gastrocnemius and soleus motor nerve branches.

The motor branches to the gastrocnemius and soleus muscles were dissected intra-muscularly to expose, identify, and mobilize the terminal motor rami of each motor branch prior to their integration with the motor endplates Figure 2. The identity of the terminal motor rami was confirmed with the use of a handheld, intra-operative nerve stimulator. The tourniquet was deflated for up to 20 min to permit neuromotor reperfusion prior to electrical stimulation, and patients had reversal of any paralytic agents. A 1–2-centimeter segment of approximately 60–70% of the terminal motor rami of each motor branch to the gastrocnemius and soleus was excised.

Additionally, partial motor neurectomy was performed by excising approximately 60–70% of the terminal motor rami, under loupe magnification based on intra-operative identification with a nerve stimulator, within the primary motor branch to the PT if substantial varus or inversion posture was noted during gait or at rest on physical examination Figure 3. A handheld nerve stimulator was utilized to confirm the motor fascicles to the PT prior to neurectomy. If stimulation resulted in activation of non-target muscles, those fascicles were preserved, and only those eliciting isolated PT contraction were selected for neurectomy.

Figure 3.

Motor nerve branch to the posterior tibialis.

The skin incision was closed with absorbable sutures. Postoperatively, patients were permitted to ambulate as tolerated while refraining from passive knee stretching exercises to decrease tension on the wound. A compressive dressing was applied across the knee joint to minimize edema and prevent soft tissue irritation for patients who required continued use of an ankle-foot orthosis.

Statistical analysis

Pre- and postoperative degrees of passive ankle dorsiflexion were compared using Student's two-tailed paired t-test and descriptive statistics. The normality of the distribution of differences between preoperative and postoperative degrees of dorsiflexion was assessed using the Shapiro-Wilk test. The data did not significantly deviate from normality (p = 0.057), supporting the use of the paired t-test. MAS scores were compared using non-parametric statistics. MAS grades for each extremity were compared pre- and postoperatively. A MAS of 1 and 1 + were counted as distinct grades.

Results

Patient demographics

Ten lower extremities in seven patients (five female) underwent HSN of the GSC for spastic equinus deformity at a mean age of 10 (range: 6 to 17) years. Demographic data and surgical details are included in Table 2. Surgical outcomes are detailed in Tables 3 –6. Single-stage bilateral HSN procedures were performed on three patients. In addition to HSN, four lower extremities in three patients had concurrent partial motor neurectomies of the PT to address spastic equinovarus deformity (Table 2).

Table 2.

Patient demographics, surgical details.

Patient	Age at surgery	Sex	Diagnosis	Gross Motor Function Classification System	Laterality	Concurrent procedure	Follow up (months since surgery)
1	17	F	Hereditary spastic paraparesis	2	Bilateral	PMN (PT)	6
1	17	F	Hereditary spastic paraparesis	2	Bilateral	PMN (PT)	6
2	6	F	Cerebral palsy	2	Unilateral	PMN (PT)	17
3*	10	F	Cerebral palsy	1	Unilateral	PMN (PT)	2
4*	12	M	Cerebral palsy	1	Unilateral	None	18
5	8	F	Cerebral palsy	1	Unilateral	None	20
6	8	F	Cerebral palsy	5	Bilateral	None	24
6	8	F	Cerebral palsy	5	Bilateral	None	24
7	8	M	Cerebral palsy	2	Bilateral	None	21
7	8	M	Cerebral palsy	2	Bilateral	None	21

PMN: Partial motor neurectomy; PT: Posterior tibialis; * Patient underwent muscle-tendon lengthening procedure prior to hyperselective neurectomy.

Table 3.

Range of motion, spasticity scores.

Patient	Laterality	Preop GSC MAS	Postop GSC MAS	Preop Passive DF knee at 0°	Preop Passive DF knee at 90°	Postop Passive DF knee at 0°	Postop Passive DF knee at 90°
1	R	2	1	−10°	−10°	0°	5°
1	L	3	1	−10°	−15°	10°	15°
2	L	1+	0	−20°	0°	0°	0°
3	R	4	0	−30°	−15°	−20°	−15°
4	L	4	0	−15°	−5°	5°	5°
5	L	3	0	−15°	−10°	−5°	0°
6	R	3	2	−10°	−10°	0°	10°
6	L	3	2	−10°	−10°	0°	10°
7	R	2	1+	−20°	5°	8°	15°
7	L	2	1	−20°	0°	10°	15°

MAS: Modified Ashworth Scale; GSC: Gastrocnemius-soleus complex; DF: Dorsiflexion; R: right; L: left.

Table 4.

Summary counts of spasticity scores before and after surgery.

MAS	0	1	1+	2	3	4
Preop # of Extremities	0	0	1	3	4	2
Postop # of Extremities	4	3	1	2	0	0

MAS: Modified Ashworth Scale.

Table 5.

Summary counts of extremities with various MAS grade improvements.

# of MAS Grades Improved	# of Extremities
1	3
2	3
3	1
4	1
5	2

MAS: Modified Ashworth Scale.

Table 6.

Strength before and after surgery.

Patient	Laterality	Preop PF strength	Postop PF strength	Preop DF strength	Postop DF strength
1	R	4/5	4/5	4/5	4/5
	L	4/5	4/5	4/5	4/5
2	L	3/5	3/5	2/5	2/5
3	R	1+/5	2/5	1/5	2/5
4	L	1/5	3+/5	2-/5	3+/5
5	L	N/A	4+/5	3-/5	4+/5
6	R	1/5	1/5	1/5	1/5
6	L	1/5	1/5	1/5	1/5
7	R	N/A	2/5	N/A	3/5
7	L	N/A	3/5	N/A	2/5

DF: Dorsiflexion; PF: Plantarflexion; R: right; L: left.

Status prior to intervention

All patients attempted treatment with botulinum toxin injections more than three months prior to HSN. Five patients noted substantial reduction in spasticity after botulinum toxin injections, while two patients reported no improvement of their spastic equinus deformity (patients 3 and 6). Two patients underwent prior surgery on the operative extremity, consisting of gastrocnemius fractional lengthening with percutaneous tendo-Achilles lengthening in one (patient 3) and gastrocnemius recession alone in another (patient 4, Table 2).

Six out of seven patients were ambulatory before and after surgery. One patient (patient 6) was non-ambulatory before and after surgery. GMFCS scores, noted in Table 2, remained unchanged for all patients after surgery.

MAS scores

At a mean follow up of 15 months (range: six to 24 months), all patients had a decrease in GSC MAS compared to their preoperative values. Preoperatively, 10% of extremities had a MAS of 1+, 30% had a MAS of 2, 40% had a MAS of 3, and 20% had a MAS of 4. Postoperatively, 40% of extremities had no residual spasticity, 30% had a MAS of 1, 10% had a MAS of 1+, and 20% had a MAS of 2 (Tables 3 –5).

Range of motion (ROM)

All patients exhibited improved passive dorsiflexion ROM with the knee in extension with mean improvement of 17° (SD = 8°, p = 0.00009). Passive dorsiflexion with the knee in flexion had a mean 13° of improvement (SD = 9°, p = 0.002) (Table 3).

Strength

No patients exhibited a reduction in dorsiflexion or plantarflexion strength (Table 6). Three patients had stable strength as compared to their preoperative exams. Two patients displayed improved strength with both plantarflexion and dorsiflexion.

Complications

There were no major complications. One minor complication of wound dehiscence was successfully managed with local wound care and gentle compression; there was no clinical evidence of infection and antibiotics were not required. Loss of sensation and associated hyperalgesia was noted at an early postoperative appointment for one patient, with subsequent resolution without intervention.

Need for subsequent surgery

Four patients underwent staged subsequent muscle-tendon based surgery on the ipsilateral extremity (Table 7) which included gastrocnemius recession (patient 2), Achilles tendon, PT and flexor hallucis longus lengthening (patient 4), GSC lengthening and Achilles tendon lengthening (patient 5), and gastrocnemius recession on one leg and Achilles tendon lengthening on the other (patient 7, who had bilateral HSN).

Table 7.

Subsequent surgery of the ipsilateral lower extremity.

Patient	Subsequent surgery (ipsilateral LE)	Time performed (post- initial surgery)
1	None
2	Gastrocnemius recession	11 weeks
3	None
4	Achilles tendon lengthening, PT tendon lengthening, FHL fractional lengthening	6 weeks
5	Achilles tendon lengthening, GSC lengthening	15 weeks
6	None
7	Gastrocnemius recession (R)	54 weeks
7	Achilles tendon lengthening (L)	54 weeks

LE: lower extremity; PT: Posterior tibialis; FHL: Flexor hallucis longus; GSC: Gastrocnemius soleus complex; R: Right; L: Left.

Discussion

Previous studies have also explored selective motor neurectomy in the pediatric LE, though no specific outcome measures were reported.^15,19,20 The current study found that HSN 1) effectively reduces spasticity in the GSC, 2) improves passive ankle dorsiflexion, 3) preserves strength and sensation and 4) is safe for pediatric patients in early-term follow-up.

Previous studies have demonstrated the safety and efficacy of HSN in the pediatric upper extremity.¹⁰ Leclercq et al. prospectively examined pediatric patients who underwent HSN of the upper extremity. All patients had reduced spasticity and improved spontaneous posturing and self-reported functionality at a mean follow-up of 15 months. There were no immediate postoperative complications and long-term patient satisfaction was high.^3,11,19–21

Several studies have examined partial motor neurotomy and selective motor neurectomy in the adult LE.^3,11,21–23 Decq et al. prospectively examined adult patients who underwent partial motor neurotomy of the tibial nerve to the soleus and partial motor neurotomy of the PT and/or toe flexors if indicated. Spasticity was eliminated in 44 of 46 patients, and ankle ROM during gait was significantly increased.²² Buffenoir et al. examined 55 patients with spastic equinus deformities who were treated with selective motor neurectomy of the tibial nerve to the soleus. Passive ankle dorsiflexion significantly increased from −0.56 degrees to +6.85 degrees, and gait speed significantly increased. Early complications were noted in five patients including wound dehiscence, reflex sympathetic dystrophy and transient deafferentation pain. No late complications were observed.²³ Sindou et al. reported on 53 patients who underwent selective motor neurectomy of the tibial nerve with 51 of 62 spastic feet having resolution of spasticity, associated total pain relief and improvement in voluntary movements for up to 10 years.²²

The primary aim of neurectomy/neurotomy is to reduce spasticity without excessively weakening the muscle. Anti-gravity motor strength, at the least, is expected to be preserved even after substantial axonotmesis when at least 20–30% of the motor pathway is left intact due to collateral sprouting of motor units.²⁴ HSN, targeting the terminal motor rami prior to inserting into the motor endplate, thus has a theoretical advantage of targeting the most distal portion of the nerve, allowing a high degree of selectivity and avoiding any unintentional denervation of non-target motor or sensory nerves. Of note, alpha motor neurons attempt to compensate for partial axonal loss by collateral sprouting of new axons, in which the size and duration of motor units action potentials increase on EMG proportionally with the amount of axons divided, thus indicating the reinnervation of denervated motor endplates.^11,25 This may account for recurrence of spasticity after HSN while illustrating the need to resect a substantial proportion of motor axons at the index surgery.

In evaluating the utility of HSN for LE spasticity, it is necessary to compare it to well-established treatment modalities. SDR has been shown to effectively reduce spasticity and improve gross motor function in pediatric patients.^26–28 The most common complication for this procedure is paresthesia, leading to dysesthesia or neuropathic pain in 6% of patients.²⁹ SDR may also increase the risk of developing progressive spinal deformity, particularly in non-ambulatory children. Other complications include bladder dysfunction, gastrointestinal dysfunction, and loss of motor function.³⁰ Furthermore, SDR is not selective for specific muscle groups, but rather performed for global spasticity of the LEs. While “focal” SDR techniques have been explored to limit dorsal rootlet sectioning to specific myotomes, the approach still affects multiple muscles due to overlapping innervation and lacks the fascicular-level precision afforded by HSN. Intrathecal baclofen reduces spasticity but is associated with infection, cerebrospinal fluid leakage and other serious complications.^31–37 Additionally, patients require ongoing appointments for dosage adjustments, pump refilling and replacement. Chemodenervation including botulinum toxins, phenol, and alcohol injections, is effective but yields only temporary effects. Consequently, there is often repetitive administration under anesthesia to maintain efficacy, yet another disadvantage as it may be associated with adverse neurocognitive effects when administered to young children.³⁸ Given the risks of these treatments, HSN is emerging as an effective and long-term focal spasticity treatment option.

When evaluating patients with GSC spasticity, it is important to consider the presence or absence of contractures, as these conditions may necessitate further muscle-based surgical procedures. Patients that present with pure spasticity are ideal candidates for nerve-based surgeries such as HSN or SDR. Patients with spasticity and concomitant muscle contractures are best addressed with a staged approach involving HSN followed by muscle-tendon lengthening or transfers and joint releasing procedures. The patient cohort in the current study included a mix of these two distinct profiles, and as such, outcome should be interpreted with an awareness of this nuance.

HSN predominantly addresses spasticity but not contractures.³⁹ Patients that present with fixed deformities from predominant muscle and/or joint contractures require muscle lengthening and periarticular soft tissue release procedures. More restricted ankle dorsiflexion with the knee extended versus flexed indicates a gastrocnemius contracture. Patients with this finding may require additional interventions, such as muscle-tendon lengthening procedures, as was done in the patients who underwent subsequent procedures (Table 7). A critical concept is that nerve-based procedures, such as HSN, can effectively treat spasticity, a neurologically mediated process, and can optimize the outcome of muscle-based procedures by decreasing the underlying spastic tone.

Despite significant postoperative reductions in spasticity, no changes were observed in GMFCS levels. While spasticity reduction may improve joint mobility, comfort and ease of care, it does not necessarily translate to changes in GMFCS. The GMFCS is a broad functional measure that reflects a child's typical performance in everyday settings, which can be influenced by factors beyond spasticity—such as motor control, strength and coordination, and preexisting deformities. The GMFCS is known to be relatively stable over time, particularly in older children, and may not be sensitive enough to detect subtle improvements in mobility following isolated interventions.⁴⁰ As such, although spasticity reduction was achieved, its isolated effect may be insufficient to meaningfully alter a patient's functional classification within the GMFCS framework.

A multidisciplinary approach involving pediatric orthopedic, peripheral nerve, and foot and ankle surgeons, PMR physicians, and physical therapists is paramount in addressing spastic equinus deformity. In this cohort, patients initially consulted with PMR physicians and underwent non-operative treatments including botulinum toxin injections and oral muscle relaxants. Following a comprehensive assessment (including dynamic EMG and gait/motion analysis), a team of physiatrists and surgeons developed an individualized surgical treatment plan. HSN was followed by a six-month observation period and re-evaluation by pediatric orthopedic specialists to consider further optimization of functional outcomes through operative and non-operative modalities. Thorough evaluation by the appropriate disciplines ensures that all non-operative measures have been exhausted and allows for comprehensive surgical planning and follow-up care.

Limitations of this study include a small patient cohort with short-term follow-up. The latter is attributed to the destination medical practice that many ambulatory patients seek out. Additionally, post-operative dynamic EMG and gait analysis were not obtained but could have revealed changes in the muscle activation pattern and gait mechanics after HSN. The retrospective design and lack of a control group limit causal inference. Additionally, outcome assessments were performed by the treating surgeon in a non-blinded fashion, introducing potential assessor bias. The use of the MAS as originally described by Bohannon and Smith also presents limitations.⁴¹ While widely used, the MAS is a subjective measure with variable inter-rater reliability.^41,42 Future studies would benefit from prospective controlled designs, blinded assessment, objective functional testing, and more robust and reliable measures of spasticity and motor function.

There are a variety of surgical procedures that can improve GSC spasticity, ankle ROM, and gait in the pediatric population. Nerve-based procedures are ideal for spastic deformities; however, upstream targets for neurectomy, such as SDR, can result in sensory disturbances or weaken unintended muscles. HSN is performed at the distal terminal motor rami to mitigate occurrence of these complications. HSN for spastic equinus deformity is safe and effective in the short term for pediatric patients. However, this procedure should be examined in a larger population with long term follow-up to more definitively determine risks, benefits, and development of secondary deformities attributed to this procedure.

Footnotes

Acknowledgments

The authors have no acknowledgments

ORCID iD

Peter C Rhee

Ethical considerations

This study received ethical approval from the Mayo Clinic IRB (approval #22-009869) on 10/18/22. This is an IRB-approved retrospective study, all patient information was de-identified and patient consent was not required. Patient data will not be shared with third parties.

Author contributions

Lainey G Bukowiec: Primary author, writing and editing manuscript, data collection

Kitty Y Wu: Writing portions of the manuscript and editing the manuscript

Joline E Brandenburg: Writing portions of the manuscript and editing the manuscript

Peter C Rhee: Conception of idea, writing portions of the manuscript and editing the manuscript

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

Rhee

. Surgical management of upper extremity deformities in patients with upper motor neuron syndrome. J Hand Surg Am 2019; 44: 223–235.

Brandenburg

Fogarty

Sieck

. A critical evaluation of current concepts in cerebral palsy. Physiology (Bethesda) 2019; 34: 216–229.

Caillet

Mertens

Rabaseda

, et al. The development of gait in the hemiplegic patient after selective tibial neurotomy. Neurochirurgie 1998; 44: 183–191.

Lamontagne

, et al. Larger contribution of passive stiffness to ankle plantarflexor moment during gait after stroke. Soc Neurosci 1997; 23: 769.

Lamontagne

Malouin

Richards

. Locomotor-specific measure of spasticity of plantarflexor muscles after stroke. Arch Phys Med Rehabil 2001; 82: 1696–1704.

Brandenburg

Rabatin

Driscoll

. Spasticity interventions. Pediatr Clin North Am 2023; 70: 483–500.

Chang

, et al. A review of spasticity treatments: pharmacological and interventional approaches. Crit Rev Phys Rehabil Med 2013; 25: 11–22.

Palacio

, et al. Direct neurectomy of the motor branches of the tibial nerve in hemiplegic adults: an assessment with a mean follow-up period of 11 years. Ann Phys Rehabil Med 2010; 53: 417–433.

Brunelli

. Partial selective denervation in spastic palsies (hyponeurotization). Microsurgery 1983; 4: 221–224.

10.

Leclercq

, et al. Hyperselective neurectomy for the treatment of upper limb spasticity in adults and children: a prospective study. J Hand Surg Eur Vol 2021; 46: 708–716.

11.

Sindou

Mertens

. Selective neurotomy of the tibial nerve for treatment of the spastic foot. Neurosurgery 1988; 23: 738–744.

12.

Cheewasukanon

Osateerakun

Limpaphayom

. Recurrence of knee flexion contracture after surgical correction in children with cerebral palsy. Int Orthop 2021; 45: 1523–1530.

13.

Stoffel

. The treatment of spastic contractures. JBJS 1913; 2: 611–644.

14.

Sindou

Abdennebi

Boisson

, et al. Treatment of spastic foot by selective neurotomy of the tibial nerve. Results of a series of 31 cases. Neurochirurgie 1985; 31: 189–197.

15.

Sindou

Simon

Mertens

, et al. Selective peripheral neurotomy (SPN) for spasticity in childhood. Childs Nerv Syst 2007; 23: 957–970.

16.

Bohannon

Smith

. Interrater reliability of a modified ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207.

17.

Hwang

, et al. Innervation of calf muscles in relation to calf reduction. Ann Plast Surg 2003; 50: 517–522.

18.

Wang

H-B

, et al. Anatomic study of selective neurectomy of gastrocnemius muscle for calf reduction in Chinese. J Plast Reconstr Aesthet Surg 2013; 66: e162–e165.

19.

Fan

Milosevic

Wang

. Selective peripheral neurotomy (SPN) as a treatment strategy for spasticity. Brain Science Advances 2020; 6: 30–41.

20.

Abou-Al-Shaar

Mahan

. Highly selective partial neurectomy for lower-extremity spasticity: 2-dimensional operative video. Oper Neurosurg (Hagerstown) 2021; 20: E442–E443.

21.

Fève

, et al. Physiological effects of selective tibial neurotomy on lower limb spasticity. J Neurol Neurosurg Psychiatry 1997; 63: 575–578.

22.

Decq

, et al. Soleus neurotomy for treatment of the spastic equinus foot. Groupe d’Evaluation et de traitement de la spasticité et de la dystonie. Neurosurgery 2000; 47: 1154–1160; discussion 1160-1.

23.

Buffenoir

, et al. Spastic equinus foot: multicenter study of the long-term results of tibial neurotomy. Neurosurgery 2004; 55: 1130–1137.

24.

Mahan

. Neurectomies for treatment of stroke-related upper extremity spasticity. Neurosurg Focus Video 2023; 8: V15.

25.

Dengler

Konstanzer

Hesse

, et al. Collateral nerve sprouting and twitch forces of single motor units in conditions with partial denervation in man. Neurosci Lett 1989; 97: 118–122.

26.

Hodgkinson

, et al. Selective dorsal rhizotomy in children with cerebral palsy. Results in 18 cases at one year postoperatively. Stereotact Funct Neurosurg 1997; 69: 259–267.

27.

McLaughlin

, et al. The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Dev Med Child Neurol 1994; 36: 755–769.

28.

Hurvitz

, et al. Functional outcomes of childhood dorsal rhizotomy in adults and adolescents with cerebral palsy. J Neurosurg Pediatr 2013; 11: 380–388.

29.

Jeffery

SMT

, et al. Surgical outcomes of single-level bilateral selective dorsal rhizotomy for spastic diplegia in 150 consecutive patients. World Neurosurg 2019; 125: e60–e66.

30.

Tedroff

Hägglund

Miller

. Long-term effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol 2020; 62: 554–562.

31.

National Collaborating Centre for Women’s and Children’s Health (UK) . Spasticity in children and young people with non-progressive brain disorders: Management of spasticity and co-existing motor disorders and their early musculoskeletal complications. London: RCOG Press, 2014.

32.

Simon

Yelnik

. Managing spasticity with drugs. Eur J Phys Rehabil Med 2010; 46: 401–410.

33.

Romijn

van Lieshout

Velis

. Reversible coma due to intrathecal baclofen. Lancet 1986; 2: 696.

34.

Coffey

, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83: 735–741.

35.

Reeves

Stolp-Smith

Christopherson

. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil 1998; 79: 353–356.

36.

Vova

, et al. A consensus statement on the use of botulinum toxin in pediatric patients. PM R 2022; 14: 1116–1142.

37.

Ploypetch

Kwon

J-Y

Armstrong

, et al. A retrospective review of unintended effects after single-event multi-level chemoneurolysis with Botulinum toxin-A and phenol in children with cerebral palsy. PM R 2015; 7: 1073–1080.

38.

Xiao

, et al. General anesthesia in children and long-term neurodevelopmental deficits: a systematic review. Front Mol Neurosci 2022; 15: 972025.

39.

Molund

, et al. Validation of a new device for measuring isolated gastrocnemius contracture and evaluation of the reliability of the silfverskiöld test. Foot Ankle Int 2018; 39: 960–965.

40.

Huroy

, et al. Stability of the gross motor function classification system over time in children with cerebral palsy. Dev Med Child Neurol 2022; 64: 1487–1493.

41.

Bohannon

Smith

. Interrater reliability of a modified ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207.

42.

Abolhasani

, et al. Comparing the validity of the modified modified ashworth scale (MMAS) and the modified tardieu scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study. BMJ Open 2012; 2: e001394.

Hyperselective neurectomy for spastic equinovarus in pediatric patients with hypertonia

Abstract

Purpose

Methods

Results

Conclusion

Keywords

Introduction

Methods

Clinical patient cohort

Outcome measures

Multidisciplinary approach

Surgical technique

Statistical analysis

Results

Patient demographics

Status prior to intervention

MAS scores

Range of motion (ROM)

Strength

Complications

Need for subsequent surgery

Discussion

Footnotes

Acknowledgments

ORCID iD

Ethical considerations

Author contributions

Funding

Declaration of conflicting interests

References